TrialNature communications2026

Prolonged β2-agonist treatment enhances muscle-specific glucose uptake in individuals with overweight and obesity: a randomized placebo-controlled trial.

Pip M G Van Lier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.